Intravenous vitamin C: yes or not? https://t.co/EjwJeM4fKv #mortality #sepsisChock #vitamineC #AIC #FICS #SRLF @Lee https://t.co/1P6Y1qJ9qi
RT @randell_hendley: @stopvaccinating https://t.co/O9RvR9v2K2 Term limits for Congress!
@stopvaccinating https://t.co/O9RvR9v2K2 Term limits for Congress!
RT @lzyii: The use of IV Vitamin C monotherapy may be associated with reduced mortality in critically ill patients. However, the certainty…
RT @CriticalCareNu1: We suggest that the quest to search for the optimal IV vit C dosage, timing, treatment duration as well as which ICU p…
RT @lzyii: The use of IV Vitamin C monotherapy may be associated with reduced mortality in critically ill patients. However, the certainty…
RT @CriticalCareNu1: We suggest that the quest to search for the optimal IV vit C dosage, timing, treatment duration as well as which ICU p…
RT @lzyii: The use of IV Vitamin C monotherapy may be associated with reduced mortality in critically ill patients. However, the certainty…
We suggest that the quest to search for the optimal IV vit C dosage, timing, treatment duration as well as which ICU pt population that may benefit the most from this therapy should be continued within the boundaries of well-designed RCTs https://t.co/V7f2
RT @lzyii: The use of IV Vitamin C monotherapy may be associated with reduced mortality in critically ill patients. However, the certainty…
RT @lzyii: The use of IV Vitamin C monotherapy may be associated with reduced mortality in critically ill patients. However, the certainty…
RT @lzyii: The use of IV Vitamin C monotherapy may be associated with reduced mortality in critically ill patients. However, the certainty…
RT @lzyii: The use of IV Vitamin C monotherapy may be associated with reduced mortality in critically ill patients. However, the certainty…
Intravenous vitamin C monotherapy in critically ill patients: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis https://t.co/oQYMMxmdKt
The use of IV Vitamin C monotherapy may be associated with reduced mortality in critically ill patients. However, the certainty of the evidence is low, and we need more robust trials. https://t.co/w8hjUZwkl9 @DarenHeyland @CStoppe @CharlesLew28 @ShahOn